Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Abnormal cardiac uptake of 123I-metaiodobenzylguanidine (123I-MIBG) is a diagnostic marker of Lewy body diseases (LBDs), e.g., Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Planar imaging is generally used to assess cardiac sympathetic dysfunction in 123I-MIBG scintigraphy; however, its clinical utility requires further improvement. We hypothesized that the co-registration of single-photon emission tomography (SPECT) and computed tomography (CT) images would improve the diagnostic accuracy of 123I-MIBG cardiac scintigraphy for LBDs. This study sought to evaluate the effects of SPECT/CT imaging on 123I-MIBG cardiac scintigraphy for diagnosing LBDs.
Methods: We retrospectively investigated data of 54 patients (consecutive 18 patients in each PD, DLB, and idiopathic normal pressure hydrocephalus [iNPH] groups) who underwent 123I-MIBG cardiac scintigraphy (planar and SPECT/CT) because of suspected LBDs at the Tohoku University hospital from June 2012 to June 2015. We compared the diagnostic accuracies of the conventional planar 123I-MIBG method and SPECT/CT methods (manual and semi-automatic).
Results: In the conventional planar analysis, 123I-MIBG uptake decreased only in the DLB group compared with the iNPH group. In contrast, the SPECT/CT analysis revealed significantly lower 123I-MIBG uptake in both the PD and DLB groups compared with the iNPH group. Furthermore, a receiver operating characteristic analysis revealed that both the manual and semi-automatic SPECT/CT methods were superior to the conventional planar method in differentiating the 3 disorders.
Conclusions: SPECT/CT 123I-MIBG cardiac scintigraphy can detect mild cardiac sympathetic dysfunction in LDBs. Our results suggest that the SPECT/CT technique improves diagnostic accuracy for LBDs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824520 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0152746 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
MIBG Scintigraphy and Arrhythmic Risk in Myocarditis.
Biomedicines
August 2025
Humanitas Gavazzeni, Via Mauro Gavazzeni, 21, 24125 Bergamo, BG, Italy.
The widespread use of cardiac magnetic resonance imaging (MRI) in clinical practice has enabled the identification of numerous patients with evident damage from previous myocarditis, whether known or unknown. For years, myocardial fibrosis has been a topic of interest due to its established correlation with arrhythmic events in various clinical settings, including ischemic heart disease, dilated cardiomyopathy, and hypertrophic cardiomyopathy. MIBG scintigraphy is a method widely used in patients who are candidates for defibrillator implantation or have experienced heart failure.
View Article and Find Full Text PDFImprovements of cardiac function and metabolic parameters by sodium-glucose cotransporter 2 inhibitors with no significant effects on sympathetic or parasympathetic activity in chronic heart failure.
Heart Vessels
August 2025
Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-Machi, Kurume, 830- 0011, Japan.
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have demonstrated significant cardiovascular benefits, including reductions in hospitalizations and mortality among patients with heart failure (HF). However, the mechanisms underlying these benefits, particularly their effects on autonomic nervous system activity, remain incompletely understood. This single-center, prospective observational study included 11 patients with chronic HF who were newly initiated on SGLT2 inhibitors.
View Article and Find Full Text PDFCardiac 123I-meta-iodobenzylguanidine Imaging as a Biomarker for Body-first Parkinson's Disease: Linking Peripheral α-Synuclein to Clinical Subtyping.
J Mov Disord
August 2025
Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Recent neuropathological and imaging studies support the concept of "brain-first vs. body-first" Parkinson's disease (PD), based on the α-Synuclein Origin site and Connectome model. The body-first phenotype is characterized by early involvement of the peripheral autonomic nervous system, particularly the cardiac sympathetic nerves and enteric nerves.
View Article and Find Full Text PDFCardiac mechanical synchrony couples with myocardial sympathetic innervation. A retrospective study with novel echocardiographic assessment in patients with I-mIBG imaging.
Eur J Nucl Med Mol Imaging
July 2025
Casa di Cura San Michele, Maddaloni, Caserta, Italy.
Purpose: Left ventricular (LV) mechanical synchrony is essential for efficient cardiac function, and its disruption (dyssynchrony) negatively impacts outcomes, particularly in heart failure. Although sympathetic innervation modulates electrical activation and contraction timing, its relationship with mechanical synchrony is underexplored. This study aimed to assess their association using echocardiographic synchrony indices and I-mIBG scintigraphy, introducing a novel index (AMP-sync).
View Article and Find Full Text PDFEstablishment of a I-meta-iodobenzylguanidine normal database for D-SPECT using Japanese and Italian data.
Ann Nucl Med
September 2025
Department of Nuclear Medicine, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-8640, Japan.
Purpose: We aimed to develop I-meta-iodobenzylguanidine (MIBG) normal databases (NDBs) for D-SPECT that included Japanese and European populations and to validate the ability of combined NDBs to diagnose heart failure (HF).
Methods: This study included 55 Japanese and 33 Italian patients without cardiac or neurological diseases associated with Lewy bodies. Single-photon emission computed tomography (SPECT) images were acquired 20 min and 3-4 h after I-MIBG injection.